These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 16945455

  • 1. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T, Onoda K.
    Vaccine; 2007 Jan 05; 25(3):570-6. PubMed ID: 16945455
    [Abstract] [Full Text] [Related]

  • 2. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.
    Shu M, Liu Q, Wang J, Ao R, Yang C, Fang G, Wan C, Guo W.
    Vaccine; 2011 Apr 18; 29(18):3507-10. PubMed ID: 19909830
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Dec 11; 58(48):1351-6. PubMed ID: 20010511
    [Abstract] [Full Text] [Related]

  • 6. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN, Bryant NJ, Andrews NJ, Bowley JS, Ohrling A, Verity CM, Ross EM, Miller E.
    Pediatrics; 2007 Aug 11; 120(2):314-21. PubMed ID: 17671057
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM, LAIV Study Group.
    Pediatrics; 2008 Mar 11; 121(3):508-16. PubMed ID: 18310199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
    Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E.
    Lancet; 1995 Mar 04; 345(8949):567-9. PubMed ID: 7619183
    [Abstract] [Full Text] [Related]

  • 12. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.
    Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM.
    Vaccine; 2009 Jul 09; 27(32):4278-83. PubMed ID: 19450636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y, Aron-Maor A.
    J Autoimmun; 2000 Feb 09; 14(1):1-10. PubMed ID: 10648110
    [Abstract] [Full Text] [Related]

  • 15. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
    Liu Y, Lin H, Zhu Q, Wu C, Zhao Z, Zheng H.
    Vaccine; 2014 Mar 26; 32(15):1768-73. PubMed ID: 24503272
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA.
    Am J Epidemiol; 2012 Jun 01; 175(11):1120-8. PubMed ID: 22582207
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.